InVivoPlus recombinant CTLA-4-Ig (hum/hum) BP0099-R050mg from Bio X Cell | Biocompare.com

Supplier Images

InVivoPlus recombinant CTLA-4-Ig (hum/hum)
InVivoPlus recombinant CTLA-4-Ig (hum/hum)

Be the first to write a review!

Citations:

Supplier Page from
Bio X Cell for
InVivoPlus recombinant CTLA-4-Ig (hum/hum)

Bio X Cell's InVivoPlus recombinant CTLA-4-Ig (hum/hum) monoclonal antibody. This antibody has been shown to work in applications such as: In Vivo, and Block/Neutralize/Inhibit.

Product Specs
ItemInVivoPlus recombinant CTLA-4-Ig (hum/hum)
CompanyBio X Cell
Price $4,277.50Supplier Page View Company Product Page
Catalog NumberBP0099-R050mg
Quantity50 mg
ConcentrationLot-Specific
Conjugate/TagUnconjugated
FormatPBS, pH 7.0, Contains no stabilizers or preservatives, Liquid
Purity≥95% Determined by SDS-PAGE
TypeFusion Protein
CloneCTLA-4-Ig (hum/hum)
Research AreaCancer Biology, Immune Checkpoint Protein, Immunology
StorageThe antibody solution should be stored at the stock concentration at 4°C. Do not freeze
ModificationsNo
OriginUnited States
Antibody TypePrimary Antibody
Applicationsin vivo Neutralization & Blocking

Specifications/Features

Quantities Available: 5mg, 25mg, 50mg, 100mg, Additional Custom Sizing Available on bioxcell.com

Add to Compare List

Bio X Cell

Bio X Cell

39 Labombard Rd

Lebanon, NH 03766

United States

Phone: 1-866-787-3444

Email: customerservice@bioxcell.com

Company Profile

Website: bioxcell.com

(1) Functional characterization of human T cell hyporesponsiveness induced by CTLA4-IgPloS oneJanuary 1, 2015Rochman Y, Yukawa M, Kartashov AV, Barski A.

(2) Transient combination therapy targeting the immune synapse abrogates T cell responses and prolongs allograft survival in micePloS oneJanuary 1, 2013Schroder PM, Khattar M, Deng R, Xie A, Chen W, Stepkowski SM.

(3) Murine regulatory T cells contain hyperproliferative and death-prone subsets with differential ICOS expressionJournal of immunology (Baltimore, Md. : 1950)February 15, 2012Chen Y, Shen S, Gorentla BK, Gao J, Zhong XP.

(4) Anti-complement component C5 mAb synergizes with CTLA4Ig to inhibit alloreactive T cells and prolong cardiac allograft survival in miceAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant SurgeonsJuly 1, 2011Raedler H, Vieyra MB, Leisman S, Lakhani P, Kwan W, Yang M, Johnson K, Faas SJ, Tamburini P, Heeger PS.

(5) Dynamic quantification of host Schwann cell migration into peripheral nerve allograftsExperimental neurologyOctober 1, 2010Whitlock EL, Myckatyn TM, Tong AY, Yee A, Yan Y, Magill CK, Johnson PJ, Mackinnon SE.

(6) IL-6 and TNF-alpha synergistically inhibit allograft acceptanceJournal of the American Society of Nephrology : JASNMay 1, 2009Shen H, Goldstein DR.

Be the First to Write a Review!